India is sharpening its ambitions in the healthcare manufacturing space, with the government aiming to build a $30 billion medical devices market by 2030 even as the country’s medical device exports crossed $4 billion in FY25. The development signals a broader push to turn India into a major global hub for medical technology production, backed by rising domestic demand, policy support, and an expanding manufacturing base.
The medical devices sector sits at the intersection of public health, industrial growth, and trade competitiveness. From diagnostic equipment and surgical instruments to implants, consumables, and hospital technologies, the industry has become increasingly important as healthcare systems worldwide invest more heavily in early diagnosis, digital care, and resilient supply chains. For India, the sector represents not only a commercial opportunity but also a strategic one.
Why the 2030 target matters
A $30 billion market target by 2030 reflects the scale of India’s aspirations in a segment long dominated by imports and by established global manufacturers from the United States, Europe, and parts of East Asia. India has traditionally been known more for pharmaceuticals than for sophisticated medical devices, but that gap has been narrowing as domestic firms improve their capabilities and multinational companies expand manufacturing and sourcing operations in the country.
The crossing of the $4 billion export mark in FY25 is significant because it suggests Indian manufacturers are not only serving local hospitals and clinics but are also becoming more relevant in international markets. A stronger export base can help companies achieve economies of scale, improve quality standards, and invest more in research, product development, and regulatory compliance. In manufacturing industries such as medical devices, scale often determines long-term competitiveness.
How India got here
India’s medical devices industry has evolved steadily over the past two decades, driven by rising healthcare spending, expanding hospital infrastructure, and growing awareness of the need for accessible diagnostics and treatment technologies. The Covid-19 pandemic also acted as a turning point. It exposed the risks of dependence on imported critical equipment and accelerated policy discussions around self-reliance, domestic production, and supply-chain security.
In recent years, the government has taken steps to support local manufacturing through industrial policy measures, infrastructure development, and efforts to create dedicated medical device parks. These initiatives are intended to reduce production costs, improve logistics, and encourage greater investment across the value chain. At the same time, India’s large and diverse patient population gives manufacturers an unusually broad domestic market in which to test, adapt, and scale products for both urban and rural healthcare settings.
Implications for healthcare and industry
If India succeeds in expanding its medical devices market, the benefits could extend well beyond factory output. Greater local production can improve availability, shorten supply lead times, and potentially lower costs for hospitals and patients. In a country where affordability remains central to healthcare access, that could have far-reaching consequences for diagnostics, emergency care, chronic disease management, and surgical treatment.
The industry’s growth also matters for jobs and technology capabilities. Medical devices manufacturing typically requires a mix of engineering, precision production, quality assurance, clinical understanding, and regulatory expertise. Building strength in this sector can therefore create high-value employment and deepen India’s broader advanced manufacturing ecosystem. It may also strengthen linkages with electronics, materials science, software, and biotechnology.
The global opportunity and the road ahead
Globally, healthcare systems are looking for more diversified and dependable supply chains. That creates an opening for India, especially as companies and governments seek alternatives that combine scale, cost competitiveness, and technical capacity. A larger Indian presence in medical devices could reshape sourcing patterns in some product categories, particularly where affordability and manufacturing flexibility are critical.
Still, the path to a $30 billion market will depend on more than demand alone. The sector will need continued progress in quality standards, regulatory predictability, innovation, and export readiness. Success in medical devices is closely tied to trust: hospitals, doctors, and patients must be confident that products meet rigorous performance and safety expectations.
For readers, this story matters because it touches everyday healthcare. A stronger domestic medical devices industry could eventually influence the price, availability, and quality of tools used in diagnosis and treatment across India. It is also a window into how the country is trying to move up the manufacturing value chain, turning health needs at home into an economic opportunity abroad. With exports already crossing $4 billion in FY25, the government’s 2030 target now looks less like a distant aspiration and more like a test of whether India can convert momentum into lasting global relevance.
